Open access · CC-BY
via OpenAlex
Rapamycin Treatment of Tendon Stem/Progenitor Cells Reduces Cellular Senescence by Upregulating Autophagy
Daibang Nie, Jianying Zhang, Yiqin Zhou, Jiuyi Sun, Wang Wang, James H‐C. Wang
Stem Cells International · 2021 · ▲ 41 citations
Deregulated nutrient-sensing
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Disabled macroautophagy
Rapamycin / mTOR inhibition
Cell culture / in vitro
Rat
In vitro
Abstract
The elderly population is prone to tendinopathy due to aging-related tendon changes such as cellular senescence(definition) and a decreased ability to modulate inflammation. Aging can render tendon stem/progenitor cells (TSCs) into premature senescence. We investigated the effects of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), a specific mTOR inhibitor, on the senescence of TSCs. We first showed that after treatment with bleomycin in vitro, rat patellar TSCs (PTSCs) underwent senescence, characterized by morphological alterations, induction of senescence-associated β-galactosidase (SA-β-gal) activity, and an increase in p53, p21, and p62 protein expression. Senescence of PTSCs was also characterized by the elevated expression of MMP-13 and TNF-α genes, both of which are molecular hallmarks of chronic tendinopathy. We then showed that rapamycin treatment was able to reverse the above senescent phenotypes and increase autophagy(definition) in the senescent PTSCs. The activation of autophagy and senescence rescue was, at least partly, due to the translocation of HMGB1 from the nucleus to the cytosol that functions as an autophagy promoter. By reducing TSC senescence, rapamycin may be used as a therapeutic to inhibit tendinopathy development in the aging population by promoting autophagy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2021/6638249
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Nie, D., Zhang, J., Zhou, Y., Sun, J., Wang, W., & Wang, J.H. (2021). Rapamycin Treatment of Tendon Stem/Progenitor Cells Reduces Cellular Senescence by Upregulating Autophagy. <em>Stem Cells International</em>. https://doi.org/10.1155/2021/6638249
Vancouver
Nie D, Zhang J, Zhou Y, Sun J, Wang W, Wang JH. Rapamycin Treatment of Tendon Stem/Progenitor Cells Reduces Cellular Senescence by Upregulating Autophagy. Stem Cells International. 2021. doi:10.1155/2021/6638249.
BibTeX
@article{daibang2021Rapamy,
title = {Rapamycin Treatment of Tendon Stem/Progenitor Cells Reduces Cellular Senescence by Upregulating Autophagy},
author = {Daibang Nie and Jianying Zhang and Yiqin Zhou and Jiuyi Sun and Wang Wang and James H‐C. Wang},
journal = {Stem Cells International},
year = {2021},
doi = {10.1155/2021/6638249},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2017
Open access · CC-BY
Aging: Molecular Pathways and Implications on the Cardiovascular System
Stem Cells International 2017
Open access · CC-BY
Age-Related Changes in Nucleus Pulposus Mesenchymal Stem Cells: An In Vitro Study in Rats
InTech eBooks 2017
Open access · CC-BY
Allogeneic Mesenchymal Stem Cells as a Treatment for Aging Frailty
Current Osteoporosis Reports 2020
Preprint · OA
Osteocyte Cellular Senescence
Experimental gerontology 2026
Citation only
From antioxidant to senotherapeutic: Repurposing n-acetylcysteine to counteract senescence via the HuR pathway in human endothelial cells.
Stem Cells 2016
Open access · OA